
Biovail - Wikipedia
Biovail Corporation was a Canadian pharmaceutical company, operating internationally in all aspects of pharmaceutical products. Its major production facility was located in Steinbach , Manitoba. It merged with Valeant Pharmaceuticals International in 2010.
Biovail Corporation -- Company History
Biovail Corporation is a pharmaceutical company that uses its patented controlled-release technology to improve upon drugs already approved by the U.S. Food and Drug Administration. Biovail is involved in the formulation, clinical testing, registration, manufacturing, and marketing of these products throughout North America.
Biovail 2025 Company Profile: Valuation, Investors, Acquisition
Biovail is headquartered in Mississauga, Canada. What is the size of Biovail? Biovail has 1,368 total employees. What industry is Biovail in? Biovail’s primary industry is Pharmaceuticals. Is Biovail a private or public company? Biovail is a Private company. What is the current valuation of Biovail? The current valuation of Biovail is .
Drugmaker Biovail to buy Valeant in $3.3 billion deal | Reuters
2010年6月21日 · Biovail Corp <BVF.TO> is to take over U.S-based Valeant Pharmaceuticals International <VRX.N> in a complex deal that positions the enlarged firm to better serve the growing baby boomer market.
Biovail Corporation, Eugene Melnyk, Brian Crombie, John Miszuk, …
2008年3月24日 · When it ultimately became impossible to continue concealing the company's inability to meet its own earnings guidance, Biovail actively misled investors and analysts about the reasons for the company's poor performance. Biovail settled the Commission's charges and will pay a $10 million penalty.
Valeant and Biovail Agree to Merge - Fierce Pharma
2010年6月21日 · Biovail Corporation (NYSE:BVF) is a specialty pharmaceutical company engaged in the formulation, clinical testing, registration, manufacture, and commercialization of pharmaceutical products.
Factbox: Key facts about Biovail and Valeant | Reuters
2010年6月21日 · (Reuters) - Top Canadian drugmaker Biovail Corp will buy Valeant Pharmaceuticals International in a complex deal worth roughly $3.3 billion engineered by the U.S. drug maker to preserve a lower...
Biovaile
Biovaile is dedicated to improving global health through innovative technologies designed to maximize nutrient availability and promote overall well-being.
Biovail - LinkedIn
Biovail Corporation is a specialty pharmaceutical company engaged in the formulation, clinical testing, registration, manufacturing, and commercialization of pharmaceutical products.
Biovail Corporation - Mississauga, Canada - bionity.com
2010年10月25日 · Biovail Corporation is a specialty pharmaceutical company that applies advanced drug-delivery technologies to improve the clinical effectiveness of medicines. The Company's therapeutic areas of focus are central nervous system (CNS) disorders, pain management and cardiovascular disease (including Type II diabetes).